Clinical trial for Stroke, Acute
Official title Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
ClinicalTrials.gov ID: NCT06825897
What this study is testing
- What it's testing
- This study wants to find out if moving patients directly to the surgery room leads to better recovery and less disability than the usual path through the emergency department.
- Who it's for
- The study is looking for adults who have had a severe stroke caused by a blocked major blood vessel within the last 7 hours.
- What's involved
- Participants will be treated using one of two methods: either going straight to the angiography suite (a room with special cameras for blood vessels) or following the standard emergency department process.
- Time commitment
- The study follows patients to track their recovery and safety outcomes after the initial treatment.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Age: ≥ 18 years of age.
- Clinical Presentation: Present to a participating TSC with signs or symptoms suggestive of acute LVO stroke.
- Stroke Severity: Baseline NIHSS of 10 or higher.
- Presence of a qualifying LVO by CTA or MRA imaging; or
- For Large Core Patients: Patients with large core infarcts (CT-ASPECT score ≤ 5, DWI-ASPECT score ≤ 5, or infarct volume ≥ 70 cc) will be enrolled...
You likely can't join if
- Time Restrictions: Presentation to a thrombectomy-capable center more than 7 hours from LSW.
- Imaging Criteria for Interfacility Transfer Patients: At sites enrolling transfer patients, any patient arriving from an outside hospital with time...
- Hemorrhagic Stroke: Presence of intracranial hemorrhage on brain imaging in the conventional strategy as Heidelberg that renders thrombectomy...
The study team makes the final eligibility decision.
Where it is enrolling
- New Haven, Connecticut, United States
- Hollywood, Florida, United States
- Miami, Florida, United States
- Wyoming, Michigan, United States
- St Louis, Missouri, United States
- Camden, New Jersey, United States
- Hackensack, New Jersey, United States
- Newark, New Jersey, United States
- New York, New York, United States
- Toledo, Ohio, United States
- Charleston, South Carolina, United States
- El Paso, Texas, United States
- Harlingen, Texas, United States
- Houston, Texas, United States
- Plano, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at New Haven, Connecticut, United States; Hollywood, Florida, United States; Miami, Florida, United States; Wyoming, Michigan, United States; St Louis, Missouri, United States; Camden, New Jersey, United States and 9 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.